Effect of ioxaglate—an ionic low osmolar contrast medium—on fibrin polymerization in vitro

1993 ◽  
Vol 4 (5) ◽  
pp. 689-697 ◽  
Author(s):  
O. Brass ◽  
J. Belleville ◽  
V. Sabattier ◽  
C. Corot
1993 ◽  
Vol 4 (5) ◽  
pp. 689-697 ◽  
Author(s):  
O. Brass ◽  
J. Belleville ◽  
V. Sabattier ◽  
C. Corot

1995 ◽  
Vol 73 (03) ◽  
pp. 349-355 ◽  
Author(s):  
Pierre Toulon ◽  
Elyane Frere ◽  
Claude Bachmeyer ◽  
Nathalie Candia ◽  
Philippe Blanche ◽  
...  

SummaryThrombin clotting time (TCT) and reptilase clotting time (RCT) were found significantly prolonged in a series of 72 HIV-infected patients drawn for routine coagulation testing. Both TCT and RCT were highly significantly correlated with albumin (r = -0.64, and r = -0.73 respectively, p<0.0001). TCT and RCT were significantly higher (p<0.0001) in a series of 30 other HIV-infected patients selected on their albumin level below 30.0 g/l (group l) than in 30 HIV-infected patients with albumin level above 40.0 g/l or in 30 HIV-negative controls; the two latter groups were not different. In vitro supplementation of plasma from group 1 patients with purified human albumin up to 45.0 g/l (final concentration) lead to a dramatic shortening effect on both TCT and RCT, which reached normal values. The TCT and RCT of the purified fibrinogen solutions (2.0 g/l final concentration) were not different in the three groups, and normal polymerization curves were obtained in all cases. This further ruled out the presence of any dysfibrinogenemia in the plasma from group 1 patients. Using purified proteins, highly significant correlations were demonstrated between the albumin concentration and the prolongations of both TCT and RCT, which were of the same magnitude order than those found in the patients plasma. These results suggest that hypo-albuminemia is responsible for the acquired fibrin polymerization defect reported in HIV-infected patients. The pathophysiological implication of the low albumin levels was suggested by the finding of decreased albumin levels (associated with prolonged TCT and RCT) in a small series of the eight HIV-infected patients who developed thrombotic complications.


1998 ◽  
Vol 39 (4) ◽  
pp. 372-374 ◽  
Author(s):  
K. J. Berg ◽  
B. Rolfsen ◽  
G. Stake

Purpose, Material and Methods, and Results: The dialyzability of the high-molecular X-ray contrast medium iodixanol was examined in an in vitro hemo-dialysis model using two different hollow fiber membranes: one high-flux (polysulfone) membrane and one intermediate-flux (cellulose triacetate) membrane. Blood flow was 200 ml/min and membrane area 1.3 m2. The dialyzer clearance of iodixanol dissolved in a mixture of leukocyte-filtered SAG-M blood and compatible citrate plasma was 134.2±3.6 ml/min for the polysulfone membrane and 113.0±3.6 ml/min for the cellulose triacetate membrane. Conclusion: Iodixanol is readily dialyzed through commercial high-flux membranes.


1984 ◽  
Vol 25 (4) ◽  
pp. 337-342 ◽  
Author(s):  
D. H. Carr ◽  
A. C. Walker

The rate of conversion in vitro, of prekallikrein to kallikrein has been measured in 74 reactors to contrast medium and 70 controls. The conversion rate is significantly more rapid in reactors than controls. There was no difference in C1-esterase inhibitor and factor XII levels between reactors and controls. This retrospective investigation suggests that prekallikrein/kallikrein conversion rate may form the basis of a test for differentiating between reactors and non-reactors.


2014 ◽  
Vol 58 (3) ◽  
pp. 385-393 ◽  
Author(s):  
Jian Song ◽  
Xifu Wang ◽  
Xiaoli Xu ◽  
Binbin Jia ◽  
Qinni Zheng ◽  
...  

2009 ◽  
Vol 41 (4) ◽  
pp. 379-383 ◽  
Author(s):  
A. NAGY ◽  
G. BODO ◽  
S. J. DYSON ◽  
F. SZABO ◽  
A. R. S. BARR

Sign in / Sign up

Export Citation Format

Share Document